SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-253527
Filing Date
2023-10-10
Accepted
2023-10-10 16:49:04
Documents
13
Period of Report
2023-10-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d514763d8k.htm   iXBRL 8-K 56675
  Complete submission text file 0001193125-23-253527.txt   225178

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA amam-20231010.xsd EX-101.SCH 4112
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amam-20231010_def.xml EX-101.DEF 14407
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amam-20231010_lab.xml EX-101.LAB 24012
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amam-20231010_pre.xml EX-101.PRE 15255
7 EXTRACTED XBRL INSTANCE DOCUMENT d514763d8k_htm.xml XML 6147
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma Inc. (Filer) CIK: 0001836056 (see all company filings)

IRS No.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40505 | Film No.: 231318493
SIC: 2836 Biological Products, (No Diagnostic Substances)